Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study

التفاصيل البيبلوغرافية
العنوان: Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study
المؤلفون: Christel Renoux, Valerie Patenaude, Samy Suissa
المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
بيانات النشر: Blackwell Publishing Ltd, 2014.
سنة النشر: 2014
مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Time Factors, Adolescent, Databases, Factual, Epidemiology, sex difference, Population, Rate ratio, arrhythmia, Young Adult, Age Distribution, Sex Factors, Risk Factors, Cause of Death, Case fatality rate, Atrial Fibrillation, Medicine, Humans, fibrillation, Sex Distribution, education, Child, Cause of death, Original Research, Aged, Aged, 80 and over, education.field_of_study, business.industry, Incidence (epidemiology), Incidence, case‐fatality, Age Factors, Infant, Newborn, Quebec, Infant, Middle Aged, mortality, Confidence interval, Child, Preschool, Cohort, Female, Cardiology and Cardiovascular Medicine, business
الوصف: Background It is unclear whether the incidence of non‐valvular atrial fibrillation ( NVAF ) has been increasing over time. We aimed to provide contemporary estimates of the incidence and case‐fatality of NVAF in a well‐defined population. Methods and Results We used the computerized databases of the Régie de l'assurance maladie du Québec ( RAMQ ), responsible for administering the universal health care services for all its residents, to identify a population‐based cohort of 243 800 patients with an incident diagnosis of NVAF during 2000–2009. The incidence rate of NVAF , age‐ and sex‐standardized to the 2004 population of Québec, was 32.4 (95% confidence interval, 32.3 to 32.5) per 10 000 per year. There was no evidence of an increasing incidence of NVAF during the 10‐year study period. The incidence rate was higher in men compared with women (age‐adjusted incidence rate ratio 1.51; 95% CI 1.50 to 1.52). The 30‐day case‐fatality was 9.2% (95% CI 9.0 to 9.3), higher for men (10.0%; 95% CI 9.8 to 10.1) than women (8.5; 95% CI 8.3 to 8.6), and increasing with age, ranging from around 1% for cases aged Conclusion Current incidence estimates illustrate the significant burden of NVAF . Mortality remains particularly high around the time of diagnosis, and case‐fatality increases with age, being systematically higher in men than women.
اللغة: English
تدمد: 2047-9980
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f15c19e747fa89c9d6b6b73e4f8db9Test
http://europepmc.org/articles/PMC4338735Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....28f15c19e747fa89c9d6b6b73e4f8db9
قاعدة البيانات: OpenAIRE